ECM
AYTU icon

ExodusPoint Capital Management’s AYTU BioPharma AYTU Stock Holding History

ExodusPoint Capital Management’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-800
Closed -$46K – 2158
2021
Q3 		$46K Sell
800
-1,893
-70% -$142K ﹤0.01% 1976
2021
Q2 		$270K Buy
+2,693
New +$316K ﹤0.01% 1803
2020
Q2 		– Sell
-200
Closed -$60K – 1765
2020
Q1 		$60K Buy
+200
New +$38.6K ﹤0.01% 945

Other funds holding AYTU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PSC
Piper Sandler & Co Minneapolis, Minnesota $102M AUM 0.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ExodusPoint Capital Management's AYTU Position: Q4 2021 in Review

ExodusPoint Capital Management sold out of AYTU BioPharma (AYTU) in Q4 2021, closing a stake of 800 shares — an estimated $46K sold.

ExodusPoint Capital Management first reported a position in AYTU in Q1 2020 and held it in 3 quarters. The position peaked at $270K in Q2 2021. 37 funds tracked by Wall St. Rank hold AYTU as of Q4 2021.

  • ExodusPoint Capital Management reported no remaining AYTU BioPharma position as of Q4 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 800 AYTU BioPharma shares in Q4 2021, an estimated $46K.
  • ExodusPoint Capital Management first reported a position in AYTU BioPharma in Q1 2020 and held it in 3 quarters.
  • ExodusPoint Capital Management's AYTU BioPharma position peaked at $270K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.